Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Validation of the SGRQ-I derived from SGRQ

Thomas Skovhus Prior, Nils Hoyer, Saher Burhan Shaker, Jesper Rømhild Davidsen, Ole Hilberg, Haridarshan Patel, Elisabeth Bendstrup
European Respiratory Journal 2021 58: PA3750; DOI: 10.1183/13993003.congress-2021.PA3750
Thomas Skovhus Prior
1Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Thomas_prior@hotmail.com
Nils Hoyer
2Department of Respiratory Medicine, Herlev and Gentofte Hospital, Hellerup, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saher Burhan Shaker
2Department of Respiratory Medicine, Herlev and Gentofte Hospital, Hellerup, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesper Rømhild Davidsen
3Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ole Hilberg
4Department of Respiratory Medicine, Vejle Hospital, Vejle, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haridarshan Patel
5Evidence Generation and Epidemiology, Global Medical Affairs, Galapagos NV, Mechelen, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Bendstrup
1Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Patients (pts) with idiopathic pulmonary fibrosis (IPF) have impaired health-related quality of life (HRQL). The St. George’s Respiratory Questionnaire (SGRQ) is also available in an IPF specific version (SGRQ-I). The aim of this study was to transform SGRQ into a derived version of SGRQ-I (SGRQ-Ider), to examine the validity of SGRQ-Ider and to compare SGRQ-Ider to the original SGRQ-I.

Methods: SGRQ results were transformed into SGRQ-Ider in a cohort used to validate SGRQ-I. At baseline (BL) and 12 months, pts completed SGRQ, SGRQ-I, K-BILD, UCSD Shortness of Breath questionnaire, SF-36, and pulmonary function tests (PFT). Both cross-sectional and longitudinal validation were performed.

Results: Questionnaires were completed by 150 pts at BL and 124 pts at 12 months. At BL, internal consistency was high in SGRQ-Ider (Cronbach’s α: 0.92). Good concurrent validity of SGRQ-Ider compared to SGRQ-I was demonstrated by a high intraclass correlation coefficient (ICC 2,1: 0.99), Bland Altman plot, moderate to strong correlations with other HRQL instruments (r=0.46–0.80) and weaker correlations with PFT (r=0.29–0.51). A high ICC (0.91) and a Bland Altman plot indicated good test-retest reliability. SGRQ-Ider was able to discriminate pts with different stages of disease based on PFT, oxygen therapy and GAP index. Responsiveness was demonstrated by moderate to strong correlations of change from BL in SGRQ-Ider with other HRQL instruments (r=0.55–0.95) and weaker correlations with PFT (r=0.24–0.48). Minimal clinically important difference after 12 months for improvement was 3.5 and 5.7 for deterioration.

Conclusion: The SGRQ-Ider is valid both cross-sectionally and longitudinally and performs comparably to SGRQ-I. This was a collaborative study.

  • Idiopathic pulmonary fibrosis
  • Measurement properties
  • Quality of life

Footnotes

Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3750.

This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2021
Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Validation of the SGRQ-I derived from SGRQ
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Validation of the SGRQ-I derived from SGRQ
Thomas Skovhus Prior, Nils Hoyer, Saher Burhan Shaker, Jesper Rømhild Davidsen, Ole Hilberg, Haridarshan Patel, Elisabeth Bendstrup
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3750; DOI: 10.1183/13993003.congress-2021.PA3750

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Validation of the SGRQ-I derived from SGRQ
Thomas Skovhus Prior, Nils Hoyer, Saher Burhan Shaker, Jesper Rømhild Davidsen, Ole Hilberg, Haridarshan Patel, Elisabeth Bendstrup
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3750; DOI: 10.1183/13993003.congress-2021.PA3750
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Association between FVC and mortality or survival in idiopathic pulmonary fibrosis: a systematic literature review
  • PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
  • Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma
Show more Idiopathic interstitial pneumonias

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society